Nicholas Investment Partners, LP Argenx Se Transaction History

Nicholas Investment Partners, LP

  • $900 Million
  • Q3 2024

A detailed history of Nicholas Investment Partners, LP transactions in Argenx Se stock. As of the latest transaction made, Nicholas Investment Partners, LP holds 8,251 shares of ARGX stock, worth $4.66 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares
8,251
Holding current value
$4.66 Million
% of portfolio
0.5%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$434.22 - $551.9 $3.58 Million - $4.55 Million
8,251 New
8,251 $4.47 Million
Q4 2023

Feb 07, 2024
SELL
$338.91 - $506.01 $26.3 Million - $39.3 Million
-77,647 Reduced 82.99%
15,919 $6.06 Million
Q3 2023

Nov 13, 2023
SELL
$369.35 - $548.43 $682,558 - $1.01 Million
-1,848 Reduced 1.94%
93,566 $46 Million
Q2 2023

Aug 09, 2023
SELL
$360.14 - $422.58 $8.36 Million - $9.81 Million
-23,211 Reduced 19.57%
95,414 $37.2 Million
Q1 2023

May 11, 2023
BUY
$334.23 - $403.65 $17.5 Million - $21.2 Million
52,480 Added 79.34%
118,625 $44.2 Million
Q4 2022

Feb 10, 2023
SELL
$342.17 - $402.31 $35,585 - $41,840
-104 Reduced 0.16%
66,145 $25.1 Million
Q3 2022

Nov 14, 2022
SELL
$343.2 - $395.75 $4.73 Million - $5.45 Million
-13,776 Reduced 17.21%
66,249 $23.4 Million
Q2 2022

Aug 10, 2022
SELL
$269.58 - $378.88 $4.4 Million - $6.19 Million
-16,335 Reduced 16.95%
80,025 $30.3 Million
Q1 2022

May 10, 2022
BUY
$254.45 - $351.06 $5.33 Million - $7.35 Million
20,928 Added 27.74%
96,360 $30.4 Million
Q4 2021

Feb 14, 2022
BUY
$272.01 - $353.03 $5.48 Million - $7.11 Million
20,134 Added 36.41%
75,432 $26.4 Million
Q3 2021

Nov 15, 2021
SELL
$295.0 - $350.58 $6.85 Million - $8.14 Million
-23,229 Reduced 29.58%
55,298 $16.7 Million
Q2 2021

Aug 10, 2021
SELL
$257.11 - $319.92 $1.95 Million - $2.43 Million
-7,601 Reduced 8.83%
78,527 $23.6 Million
Q1 2021

May 14, 2021
BUY
$268.3 - $380.31 $751,240 - $1.06 Million
2,800 Added 3.36%
86,128 $23.7 Million
Q4 2020

Feb 11, 2021
SELL
$248.13 - $308.36 $19,106 - $23,743
-77 Reduced 0.09%
83,328 $24.5 Million
Q3 2020

Nov 13, 2020
BUY
$215.51 - $272.51 $14.5 Million - $18.3 Million
67,170 Added 413.74%
83,405 $21.9 Million
Q2 2020

Aug 12, 2020
SELL
$127.44 - $232.72 $3.33 Million - $6.07 Million
-26,100 Reduced 61.65%
16,235 $3.66 Million
Q1 2020

May 13, 2020
BUY
$108.83 - $165.23 $112,421 - $170,682
1,033 Added 2.5%
42,335 $5.58 Million
Q4 2019

Feb 13, 2020
BUY
$106.59 - $164.21 $935,433 - $1.44 Million
8,776 Added 26.98%
41,302 $6.63 Million
Q3 2019

Nov 13, 2019
SELL
$113.31 - $150.51 $28,100 - $37,326
-248 Reduced 0.76%
32,526 $3.71 Million
Q2 2019

Aug 09, 2019
SELL
$115.0 - $141.58 $27,370 - $33,696
-238 Reduced 0.72%
32,774 $4.64 Million
Q1 2019

May 15, 2019
BUY
$98.85 - $134.59 $670,598 - $913,058
6,784 Added 25.87%
33,012 $4.12 Million
Q4 2018

Feb 14, 2019
SELL
$63.81 - $109.82 $488,720 - $841,111
-7,659 Reduced 22.6%
26,228 $2.52 Million
Q3 2018

Nov 14, 2018
SELL
$75.5 - $96.63 $46,432 - $59,427
-615 Reduced 1.78%
33,887 $2.57 Million
Q2 2018

Aug 14, 2018
BUY
$74.84 - $100.16 $310,211 - $415,163
4,145 Added 13.65%
34,502 $2.86 Million
Q1 2018

May 15, 2018
SELL
$56.95 - $85.19 $1.05 Million - $1.58 Million
-18,516 Reduced 37.89%
30,357 $2.44 Million
Q4 2017

Feb 14, 2018
BUY
$22.57 - $63.56 $1.1 Million - $3.11 Million
48,873
48,873 $3.09 Million

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $31.2B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email